CLOct 11, 2022
MTet: Multi-domain Translation for English and VietnameseChinh Ngo, Trieu H. Trinh, Long Phan et al.
We introduce MTet, the largest publicly available parallel corpus for English-Vietnamese translation. MTet consists of 4.2M high-quality training sentence pairs and a multi-domain test set refined by the Vietnamese research community. Combining with previous works on English-Vietnamese translation, we grow the existing parallel dataset to 6.2M sentence pairs. We also release the first pretrained model EnViT5 for English and Vietnamese languages. Combining both resources, our model significantly outperforms previous state-of-the-art results by up to 2 points in translation BLEU score, while being 1.6 times smaller.
CLOct 11, 2022
Enriching Biomedical Knowledge for Low-resource Language Through Large-Scale TranslationLong Phan, Tai Dang, Hieu Tran et al.
Biomedical data and benchmarks are highly valuable yet very limited in low-resource languages other than English such as Vietnamese. In this paper, we make use of a state-of-the-art translation model in English-Vietnamese to translate and produce both pretrained as well as supervised data in the biomedical domains. Thanks to such large-scale translation, we introduce ViPubmedT5, a pretrained Encoder-Decoder Transformer model trained on 20 million translated abstracts from the high-quality public PubMed corpus. ViPubMedT5 demonstrates state-of-the-art results on two different biomedical benchmarks in summarization and acronym disambiguation. Further, we release ViMedNLI - a new NLP task in Vietnamese translated from MedNLI using the recently public En-vi translation model and carefully refined by human experts, with evaluations of existing methods against ViPubmedT5.
CLMar 30, 2024Code
Aurora-M: Open Source Continual Pre-training for Multilingual Language and CodeTaishi Nakamura, Mayank Mishra, Simone Tedeschi et al. · ibm-research, stanford
Pretrained language models are an integral part of AI applications, but their high computational cost for training limits accessibility. Initiatives such as Bloom and StarCoder aim to democratize access to pretrained models for collaborative community development. Despite these efforts, such models encounter challenges such as limited multilingual capabilities, risks of catastrophic forgetting during continual pretraining, and the high costs of training models from scratch, alongside the need to align with AI safety standards and regulatory frameworks. This paper presents Aurora-M, a 15B parameter multilingual open-source model trained on English, Finnish, Hindi, Japanese, Vietnamese, and code. Continually pretrained from StarCoderPlus on 435B additional tokens, Aurora-M surpasses 2T tokens in total training token count. It is the first open-source multilingual model fine-tuned on human-reviewed safety instructions, thus aligning its development not only with conventional red-teaming considerations, but also with the specific concerns articulated in the Biden-Harris Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence. We evaluate Aurora-M across a wide range of tasks and languages, showcasing its robustness against catastrophic forgetting and its superior performance in multilingual settings, particularly in safety evaluations. We open-source Aurora-M and its variants to encourage responsible open-source development of large language models at https://huggingface.co/aurora-m.
LGMar 21, 2025
Preferential Multi-Objective Bayesian Optimization for Drug DiscoveryTai Dang, Long-Hung Pham, Sang T. Truong et al.
Despite decades of advancements in automated ligand screening, large-scale drug discovery remains resource-intensive and requires post-processing hit selection, a step where chemists manually select a few promising molecules based on their chemical intuition. This creates a major bottleneck in the virtual screening process for drug discovery, demanding experts to repeatedly balance complex trade-offs among drug properties across a vast pool of candidates. To improve the efficiency and reliability of this process, we propose a novel human-centered framework named CheapVS that allows chemists to guide the ligand selection process by providing preferences regarding the trade-offs between drug properties via pairwise comparison. Our framework combines preferential multi-objective Bayesian optimization with a docking model for measuring binding affinity to capture human chemical intuition for improving hit identification. Specifically, on a library of 100K chemical candidates targeting EGFR and DRD2, CheapVS outperforms state-of-the-art screening methods in identifying drugs within a limited computational budget. Notably, our method can recover up to 16/37 EGFR and 37/58 DRD2 known drugs while screening only 6% of the library, showcasing its potential to significantly advance drug discovery.